Atay Oguzhan 4
4 · BillionToOne, Inc. · Filed Jul 13, 2026
Research Summary
AI-generated summary of this filing
BillionToOne (BLLN) CEO Atay Oguzhan Sells Shares, Exercises Options
What Happened
- Atay Oguzhan, BillionToOne’s Chairman and CEO, exercised 12,500 options at $2.80 per share (cost $35,000) and sold a total of 12,500 shares in multiple open-market transactions on July 9, 2026, generating approximately $1,576,276 in gross proceeds (combined weighted-average sale price ≈ $126.10/share). The option grant is fully vested.
- The activity appears routine and was executed pursuant to a Rule 10b5-1 trading plan adopted March 6, 2026.
Key Details
- Transaction date: July 9, 2026 (Form 4 filed July 13, 2026 — filed 4 days after trades; Form 4 is generally due within 2 business days).
- Exercise: 12,500 shares acquired at $2.80 each (total $35,000). (Transaction code M = option exercise.)
- Sales (total 12,500 shares) — reported as separate weighted-average groups:
- 7,489 shares at $125.43 (proceeds $939,318) — prices ranged $125.000–$125.910 (F2).
- 2,002 shares at $126.48 (proceeds $253,221) — prices ranged $126.085–$127.040 (F3).
- 2,657 shares at $127.44 (proceeds $338,599) — prices ranged $127.100–$128.060 (F4).
- 352 shares at $128.23 (proceeds $45,138) — prices ranged $128.180–$128.295 (F5).
- Combined sale proceeds: ≈ $1,576,276; net proceeds (after exercise cost of $35,000 and fees/taxes) will be lower.
- Shares owned after the transactions: not disclosed in the provided filing excerpt.
- Notable footnotes: trades were effected under a Rule 10b5-1 plan (F1); the options were fully vested and exercisable (F6).
Context
- This was an exercise of vested options followed by open-market sales (a common way executives realize option value). The filing shows the exercise and sales occurred same day, consistent with a prearranged 10b5-1 plan.
- The presence of a 10b5-1 plan means the trades were pre-specified; the filing itself being several days after the trade may be late relative to the usual 2-business-day Form 4 deadline.
Insider Transaction Report
Form 4
Atay Oguzhan
DirectorChairman and CEO
Transactions
- Exercise/Conversion
Class A Common Stock
[F1]2026-07-09$2.80/sh+12,500$35,000→ 12,500 total - Sale
Class A Common Stock
[F1][F2]2026-07-09$125.43/sh−7,489$939,318→ 5,011 total - Sale
Class A Common Stock
[F1][F3]2026-07-09$126.48/sh−2,002$253,221→ 3,009 total - Sale
Class A Common Stock
[F1][F4]2026-07-09$127.44/sh−2,657$338,599→ 352 total - Sale
Class A Common Stock
[F1][F5]2026-07-09$128.23/sh−352$45,138→ 0 total - Exercise/Conversion
Stock Option (right to buy)
[F6]2026-07-09$2.80/sh−12,500$35,000→ 575,000 totalExercise: $2.80Exp: 2031-06-07→ Class A Common Stock (12,500 underlying)
Footnotes (6)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.000 to $125.910 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.085 to $127.040 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.100 to $128.060 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.180 to $128.295 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The options are fully vested and exercisable.
Signature
/s/ Thomas P. Lynch, Attorney-in-Fact|2026-07-13